Richard Vincent
2012
In 2012, Richard Vincent earned a total compensation of $1.1M as Chief Financial Officer at Sorrento Therapeutics, a 521% increase compared to previous year.
Compensation breakdown
| Option Awards | $936,250 |
|---|---|
| Salary | $183,506 |
| Other | $4,739 |
| Total | $1,124,495 |
Vincent received $936.3K in option awards, accounting for 83% of the total pay in 2012.
Vincent also received $183.5K in salary and $4.7K in other compensation.
Rankings
In 2012, Richard Vincent's compensation ranked 5,668th out of 11,487 executives tracked by ExecPay. In other words, Vincent earned more than 50.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,668 out of 11,487 | 51st |
Division Manufacturing | 2,010 out of 4,253 | 53rd |
Major group Chemicals And Allied Products | 487 out of 1,198 | 59th |
Industry group Drugs | 327 out of 920 | 65th |
Industry Biological Products, Except Diagnostic Substances | 57 out of 160 | 64th |
Source: SEC filing on April 16, 2013.
Vincent's colleagues
We found one more compensation record of an executive who worked with Richard Vincent at Sorrento Therapeutics in 2012.
2012
Henry Ji
Sorrento Therapeutics